Procyon Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.97M | Sell |
7,329
-5,828
| -44% | -$2.36M | 0.28% | 73 |
|
|
2025
Q1 | $6.55M | Buy |
13,157
+1,556
| +13% | +$774K | 0.4% | 59 |
|
|
2024
Q4 | $6.03M | Sell |
11,601
-796
| -6% | -$414K | 0.38% | 56 |
|
|
2024
Q3 | $7.67M | Sell |
12,397
-248
| -2% | -$153K | 0.52% | 43 |
|
|
2024
Q2 | $6.99M | Buy |
12,645
+499
| +4% | +$276K | 0.52% | 47 |
|
|
2024
Q1 | $7.06M | Buy |
12,146
+2,196
| +22% | +$1.28M | 0.55% | 44 |
|
|
2023
Q4 | $5.28M | Sell |
9,950
-673
| -6% | -$357K | 0.45% | 49 |
|
|
2023
Q3 | $5.38M | Buy |
10,623
+2,987
| +39% | +$1.51M | 0.55% | 40 |
|
|
2023
Q2 | $3.98M | Buy |
7,636
+1,314
| +21% | +$686K | 0.5% | 47 |
|
|
2023
Q1 | $3.64M | Sell |
6,322
-1,291
| -17% | -$744K | 0.61% | 36 |
|
|
2022
Q4 | $4.19M | Buy |
7,613
+3,030
| +66% | +$1.67M | 0.77% | 34 |
|
|
2022
Q3 | $2.33M | Buy |
4,583
+299
| +7% | +$152K | 0.57% | 40 |
|
|
2022
Q2 | $2.33M | Buy |
4,284
+805
| +23% | +$437K | 0.51% | 44 |
|
|
2022
Q1 | $2.06M | Buy |
3,479
+1,389
| +66% | +$820K | 0.42% | 53 |
|
|
2021
Q4 | $1.4M | Buy |
2,090
+98
| +5% | +$65.4K | 0.3% | 81 |
|
|
2021
Q3 | $1.14M | Buy |
1,992
+185
| +10% | +$106K | 0.29% | 80 |
|
|
2021
Q2 | $912K | Buy |
1,807
+318
| +21% | +$160K | 0.25% | 89 |
|
|
2021
Q1 | $680K | Buy |
1,489
+45
| +3% | +$20.6K | 0.3% | 79 |
|
|
2020
Q4 | $673K | Sell |
1,444
-23
| -2% | -$10.7K | 0.33% | 79 |
|
|
2020
Q3 | $648K | Buy |
1,467
+90
| +7% | +$39.8K | 0.36% | 75 |
|
|
2020
Q2 | $499K | Buy |
1,377
+160
| +13% | +$58K | 0.27% | 81 |
|
|
2020
Q1 | $345K | Buy |
1,217
+144
| +13% | +$40.8K | 0.23% | 90 |
|
|
2019
Q4 | $349K | Buy |
+1,073
| New | +$349K | 0.21% | 103 |
|